CoChat

The IL-33/ST2 pathway shapes the regulatory T cell phenotype to promote intestinal cancer

Open access
Pastille, Eva, Wasmer, Marie-Hélène, Adamczyk, Alexandra, Vu, Vivian P., Mager, Lukas F., Phuong, Nhi Ngo Thi, Palmieri, Vittoria, Simillion, Cedric, Hansen, Wiebke, Kasper, Stefan, Schuler, Martin, Muggli, Beat, McCoy, Kathy D., Buer, Jan, Zlobec, Inti, Westendorf, Astrid M., Krebs, Philippe · 2019 · Mucosal Immunology
Cited by 150

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

The composition of immune infiltrates strongly affects the prognosis of patients with colorectal cancer (CRC). Interleukin (IL)-33 and regulatory T cells (Tregs) in the tumor microenvironment have been separately implicated in CRC; however their contribution to intestinal carcinogenesis is still controversial. Here, we reveal that IL-33 signaling promotes CRC by changing the phenotype of Tregs. In mice with CRC, tumor-infiltrating Tregs preferentially upregulate IL-33 receptor (ST2), and IL-33/ST2 signaling positively correlates with tumor number and size. Transcriptomic and flow cytometry analyses demonstrate that ST2 expression induces a more activated and migratory phenotype in FOXP3 + Tregs, which favors their accumulation in the tumor environment. Consequently, genetic ablation of St2 reduces Treg infiltration and concomitantly enhances the frequencies of effector CD8 + T cells, thereby restraining CRC. Mechanistically, IL-33 curtails IL-17 production by FOXP3 + Tregs and inhibits Th17 differentiation. In humans, numbers of activated ST2-expressing Tregs are increased in blood and tumor lesions of CRC patients, suggesting a similar mode of regulation. Together, these data indicate a central role of IL-33/ST2 signaling in shaping an immunosuppressive environment during intestinal tumorigenesis. Blockade of this pathway may provide a strategy to modulate the composition of CRC immune infiltrates.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41385-019-0176-y

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 150

Metadata

Authors
Pastille, E., Wasmer, M.-H., Adamczyk, A., Vu, V. P., Mager, L. F., Phuong, N. N. T., Palmieri, V., Simillion, C., Hansen, W., Kasper, S., Schuler, M., Muggli, B., McCoy, K. D., Buer, J., Zlobec, I., Westendorf, A. M., & Krebs, P.
Venue
Mucosal Immunology
Publisher
Elsevier BV
Published
2019-07
Volume
12
Issue
4
Pages
990-1003
ISSN
1933-0219 (ISSN-L)
OpenAlex
W2948342839
Cited by
150
References
9
FWCI
6.89
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The IL-33/ST2 pathway shapes the regulatory T cell phenotype to promote intestinal cancer. https://app.cochat.ai/papers/10.1038/s41385-019-0176-y
The paper
Pastille, E., Wasmer, M.-H., Adamczyk, A., Vu, V. P., Mager, L. F., Phuong, N. N. T., Palmieri, V., Simillion, C., Hansen, W., Kasper, S., Schuler, M., Muggli, B., McCoy, K. D., Buer, J., Zlobec, I., Westendorf, A. M., & Krebs, P. (2019). The IL-33/ST2 pathway shapes the regulatory T cell phenotype to promote intestinal cancer. Mucosal Immunology. https://doi.org/10.1038/s41385-019-0176-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.